© 2022 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
August 16, 2021
The Major Histocompatibility Complex Class II protein has potential to predict immunotherapy benefit in two types of breast cancer.
August 11, 2021
Pregnant women who had cancer previously or currently have cancer were more likely to experience comorbidities and in-hospital complications, depending on cancer type.